TY - JOUR
T1 - Engineering of Nanofibrous Amorphous and Crystalline Solid Dispersions for Oral Drug Delivery
AU - Modica de Mohac, Laura
AU - Keating, Alison Veronica
AU - De Fatima Pina, Maria
AU - Abraham, Bahijja Tolulope
PY - 2018
Y1 - 2018
N2 - Poor aqueous solubility (<0.1 mg/mL) affects a significant number of drugs currently on the market or under development. Several formulation strategies including salt formation, particle size reduction, and solid dispersion approaches have been employed with varied success. In this review, we focus primarily on the emerging trends in the generation of amorphous and micro/nano-crystalline solid dispersions using electrospinning to improve the dissolution rate and in turn bioavailability of poorly water-soluble drugs. Electrospinning is a simple but versatile process that utilizes electrostatic forces to generate polymeric fibers and has been used for over 100 years to generate synthetic fiber. We discuss the various electrospinning studies and spinneret types that have been used to generate amorphous and crystalline solid dispersions.
AB - Poor aqueous solubility (<0.1 mg/mL) affects a significant number of drugs currently on the market or under development. Several formulation strategies including salt formation, particle size reduction, and solid dispersion approaches have been employed with varied success. In this review, we focus primarily on the emerging trends in the generation of amorphous and micro/nano-crystalline solid dispersions using electrospinning to improve the dissolution rate and in turn bioavailability of poorly water-soluble drugs. Electrospinning is a simple but versatile process that utilizes electrostatic forces to generate polymeric fibers and has been used for over 100 years to generate synthetic fiber. We discuss the various electrospinning studies and spinneret types that have been used to generate amorphous and crystalline solid dispersions.
U2 - 10.3390/pharmaceutics11010007
DO - 10.3390/pharmaceutics11010007
M3 - Review article
SN - 1999-4923
JO - Pharmaceutics
JF - Pharmaceutics
ER -